Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series

Related Experiment Video

Updated: Jul 3, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Ashya R Burgess1, Husnain Ali1, Jabra Zarka1

  • 1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.

Haematologica
|July 2, 2026
PubMed

Abstract:

Not available.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jul 3, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Articles linked to this work by shared authors, journal, and citation graph.

Combined Point Mutation in a Single Allele of the TP53 Gene Potentiates the Oncogenic and Transcriptional Properties of TP53 in Lung Cancer.

International journal of biological sciences·2026

Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial.

Haematologica·2026

Allogeneic hematopoietic stem cell transplantation rather than specific front-line therapy is associated with long-term survival in blastic plasmacytoid dendritic cell neoplasm: the Mayo Clinic experience.

Haematologica·2026

Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s).

Leukemia·2026

Evaluation of Modern Hematology-Oncology Home-Call: Optimizing Patient Care, Physician Wellbeing, and Trainee Education.

Blood advances·2026

Financial hardship in adolescent and young adult cancer survivors and adult survivors of childhood cancers.

Journal of cancer survivorship : research and practice·2026

Low incidence, high stakes: BCMA CAR-T and parkinsonism.

Haematologica·2026

BCL6 in B-cell lymphomas: old target, new tricks?

Haematologica·2026

Environmental assessment of hemophilia therapies. Comment on: "Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism".

Haematologica·2026

Platelet transfusion biology: from hemostatic support to inflammatory and immune signaling.

Haematologica·2026

Clinical risk features and genetic findings in essential thrombocythemia and polycythemia vera of childhood and adolescence: prospective insights from the German MPN Childhood Registry.

Haematologica·2026

Immunogenomic characterization of classic Hodgkin lymphoma variant of Richter transformation reveals shared biology with de novo classic Hodgkin lymphoma.

Haematologica·2026

Combined Vitamin B12 and Folate Deficiency Presenting As Pseudo-Thrombotic Microangiopathy With a Disseminated Intravascular Coagulation (DIC)-Like Coagulation Profile: A Case Report.

Cureus·2026

Latent class analysis identifies three biologically distinct phenotypes among patients undergoing endovascular thrombectomy: a derivation and temporal validation study.

Frontiers in neurology·2026

Compound heterozygous RHCE null genotype underlying D-- phenotype in a Chinese pregnant woman: molecular characterization and sequential transfusion strategy.

Frontiers in immunology·2026

Purpurin Alleviates Chemotherapy-Induced Thrombocytopenia Through Estrogen Receptor α Dependent Phosphoinositide 3-Kinase/Protein Kinase B Signalling.

Phytotherapy research : PTR·2026

Exclusion of Arteriovenous Shunts in Intracerebral Hemorrhage Using MRI Arterial Spin Labeling: A Prospective Multicenter Study.

Neurology·2026

Data Collection on Rare Coagulation Disorders: Focus on Patients with Coagulation Factor X Deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us